Maternal second trimester serum tumor necrosis factor-α-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia

American Journal of Epidemiology

Volumn 149, Issue 4, 1999, Pages 323-329

  Williams, Michelle A ^a,b,c   Farrand, Allen ^b   Mittendorf, Robert ^d   Sorensen, Tanya K ^b   Zingheim, Rosalee W ^a   O'Reilly, Geralyn C ^a   King, Irena B ^b   Zebelman, Arthur M ^e   Luthy, David A ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e DYNACARE LABORATORIES   (Canada)

Author keywords

Cytokines; Pre eclampsia; Pregnancy; Receptors, tumor necrosis factor; Tumor necrosis factor

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENDOTHELIUM INJURY; FEMALE; HIGH RISK PREGNANCY; HUMAN; IMMUNOREGULATION; MATERNAL HYPERTENSION; PREECLAMPSIA; RISK FACTOR; SECOND TRIMESTER PREGNANCY;

EID: 0033557394     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009816     Document Type: Article

References (49)

1. Zuspan FP, Samuels P. Preventing preeclampsia. N Engl J Med 1993;329:1265-6.
2. Mittendorf R, Lain KY, Williams MA, et al. Preeclampsia: a nested case-control study of risk factors and their interactions. J Reprod Med 1996;41:491-6.
3. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-41.
4. Williams MA, Zingheim RW, King IB, et al. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995;6:232-7.
5. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51.
6. Redman CW. Cytotrophoblasts: masters of disguise. Nat Med 1997;3:610-11.
7. Kaaja R, Tikkanen MJ, Viinikka L, et al. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85: 353-6.
8. Gratacos E, Casals E, Sanllehy C, et al. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996;75:896-901.
9. Hubel CA, Roberts JM, Taylor RN, et al. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989;161:1025-34.
10. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregn 1994;13:1-32.
11. Schobel HP, Fischer T, Heuszer K, et al. Preeclampsia - a state of sympathetic overactivity. N Engl J Med 1996;335:1480-5.
12. Sorensen TK, Williams MA, Zingheim RW, et al. Elevated second-trimester chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993; 169:834-8.
13. Walsh SW, Behr MJ, Allen NH. Placental prostacyclin production in normal and toxemic pregnancies. Am J Obstet Gynecol 1985;151:110-15.
14. FitzGerald DJ, Entman SS, Mulloy K, et al. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987;75:956-63.
15. Sibai BM. Immunologic aspects of preeclampsia. Clin Obstet Gynecol 1991;34:27-34.
16. Kupferminc MJ, Peaceman AM, Wigton TR, et al. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752-9.
17. Taylor RN. Review: immunobiology of preeclampsia. Am J Reprod Immunol 1997;37:79-86.
18. Vince GS, Starkey PM, Austgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;102:20-5.
19. Hunt JS, Chen H-L, Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996;54:554-62.
20. Fiers W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett 1991;285:199-212.
21. Gedeit RG. Tumor necrosis factor-induced E-selectin expression on vascular endothelial cells. Crit Care Med 1996;24:1543-6.
22. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240-9.
23. Stark JM. Pre-eclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 1993;100:105-9.
24. Orvieto R, Ben-Rafael Z. The role of cytokines in early detection of preeclampsia. Med Hypotheses 1994;43:315-18.
25. Visser W, Beckmann I, Bremer HA, et al. Bioactive tumour necrosis factor α in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994;101: 1081-2.
26. Greer IA, Lyall F, Perera T, et al. Increased concentration of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994;84:937-40.
27. Meekins JW, McLaughlin PJ, West DC, et al. Endothelial cell activation by tumour necrosis factor-alpha (TNF-α) and the development of pre-eclampsia. Clin Exp Immunol 1994;98: 110-14.
28. Hamai Y, Fujii T, Yamashita T, et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997;38:89-93.
29. Blick M, Sherwin SA, Rosenblum M, et al. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987;47:2986-9.
30. Parsons PE, Moore FA, Moore EE, et al. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 1992;146:694-700.
31. Van Zee KJ, Kohno T, Fisher E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845-9.
32. American College of Obstetricians and Gynecologists. Management of preeclampsia. (Technical bulletin no. 19). Washington, DC: American College of Obstetricians and Gynecologists, 1986.
33. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
34. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
35. Rothman K. Modern epidemiology. Boston, MA: Little, Brown and Company, 1986.
36. Wang Y, Walsh SW. TNF α concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996;32:157-69.
37. Chen G, Wilson R, Wang SH, et al. Tumour necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996;104:154-9.
38. van der Poll T, Buller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;332:1622-7.
39. Greer IA, Haddad NG, Dawes J, et al. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989; 96:978-82.
40. Perlmutter DH, Dinarello CA, Punsal PI, et al. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986;78:1349-54.
41. Feingold KR, Serio MK, Adi S, et al. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989;124:2336-42.
42. Starnes HF Jr, Warren RS, Jeevanandam M, et al. Tumor necrosis factor and the acute metabolic response to injury in man. J Clin Invest 1988;82:1321-5.
43. Semb H, Peterson J, Tavernier J, et al. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 1987;262:8390-4.
44. Meydani SN, Dinarello CA. Influences of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993;8:65-72.
45. Meydani S, Endres S, Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between younger and older women. J Nutr 1991;121:547-55.
46. Caughey GE, Mantzioris E, Gibson RA, et al. The effect on human tumor necrosis factor α and interleukin Iβ production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-22.
47. Peristeris P, Clark BD, Gatti S, et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992;140:390-9.
48. Todt JC, Yang Y, Lei J, et al. Effects of tumor necrosis factor-alpha on human trophoblast cell adhesion and motility. Am J Reprod Immunol 1996;36:65-71.
49. Das UN. Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases. Prostaglandins Leukot Essent Fatty Acids 1991;44:201-10.